In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Exploring use cases for tokenising clinical trials
In this article from In Vivo Citeline, Melissa McDonald, Director of Operations, highlights how traditional clinical studies can be costly, time consuming and burdensome on patients and sites. As a result, researchers are looking for new and innovative solutions to answer challenging research questions. One of these solutions is Clinical Trial Tokenisation.
-
The CRA of the future: From ‘road warrior’ to site ‘owner’
In this article from Applied Clinical Trials, Helen Yeardley, SVP, Global Clinical Operations explores how the role of the CRA is rapidly evolving in response to changes in clinical trials. She outlines how the industry can invest in CRA talent and apply new thinking to critical areas, including site-performance management, risk management, remote monitoring, and remote data collection.
-
Biotech in 2024: Opportunities, trends & challenges
In this video interview with Fierce Biotech, Chris Smyth, President of ICON Biotech, provides insight into the operating environment facing biotechs in 2024.
-
ICON biotech sector survey: Insights and projections shaping the industry
In this article from PM360, Chris Smyth, President of ICON Biotech, summarises the main findings from the biotech sector survey and outlines the key implications for biotech including strategic collaboration, innovation and cost optimisation.
-
Capitalising on collaboration and confidence: Survey insights and expectations for biotech in 2024
This article by Chris Smyth, President, ICON Biotech, provides an overview of the recent ICON biotech sector survey findings, and looks at the trend of biotech companies engaging earlier and more comprehensively with CROs to drive efficiencies and realise the full value of their R&D programs.
-
Optimism returns as biotech optimise R&D
In this article, Brandon Early, SVP Project Delivery, outlines some of the key findings from the ICON biotech sector survey of over 130 decision makers in small, mid-size, large biotech and VC organisations.
-
Outsourcing analytical testing: AI could transform analytical labs
In this article from Drug Development & Delivery, Suzanne Jansen, Head of QC Laboratory, discusses the importance of faster data turnaround within the analytical lab to facilitate adaptive dosing decisions that will benefit all stages of clinical trials.
-
Supporting investigators and sites in the evolution to decentralised clinical trials
In this article from International Biopharmaceutical Industry, Harpreet Gill, Vice President of Real-World Solutions - Project Management reflects on how investigators and sites can be supported and partnered as the use of decentralised clinical trials evolves.
-
Diabesity: Implications for treatment and drug development
In this Journal for Clinical Studies’ article, Simon Bruce and Jack Martin discuss the overlap in pathophysiology and treatment of diabetes and obesity along with considerations for streamlining the clinical development of treatments that have therapeutic promise for both conditions.
-
ICON announces results from survey on obesity-related clinical research
This news article, from Applied Clinical Trials, outlines findings from ICON’s recent survey of over 100 industry professionals on their opinions on future research within the therapeutic area of obesity treatment.
